These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 23359498)
21. Tyrosine kinase 2 (TYK2) in cytokine signalling and host immunity. Strobl B; Stoiber D; Sexl V; Mueller M Front Biosci (Landmark Ed); 2011 Jun; 16(9):3214-32. PubMed ID: 21622231 [TBL] [Abstract][Full Text] [Related]
22. Requirement of catalytically active Tyk2 and accessory signals for the induction of TRAIL mRNA by IFN-beta. Rani MR; Pandalai S; Shrock J; Almasan A; Ransohoff RM J Interferon Cytokine Res; 2007 Sep; 27(9):767-79. PubMed ID: 17892398 [TBL] [Abstract][Full Text] [Related]
23. Re-evaluation of IL-10 signaling reveals novel insights on the contribution of the intracellular domain of the IL-10R2 chain. Wilbers RHP; van Raaij DR; Westerhof LB; Bakker J; Smant G; Schots A PLoS One; 2017; 12(10):e0186317. PubMed ID: 29016674 [TBL] [Abstract][Full Text] [Related]
24. TYK2 kinase activity is required for functional type I interferon responses in vivo. Prchal-Murphy M; Semper C; Lassnig C; Wallner B; Gausterer C; Teppner-Klymiuk I; Kobolak J; Müller S; Kolbe T; Karaghiosoff M; Dinnyés A; Rülicke T; Leitner NR; Strobl B; Müller M PLoS One; 2012; 7(6):e39141. PubMed ID: 22723949 [TBL] [Abstract][Full Text] [Related]
25. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. Murata T; Noguchi PD; Puri RK J Immunol; 1996 Apr; 156(8):2972-8. PubMed ID: 8609418 [TBL] [Abstract][Full Text] [Related]
26. A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitors. Sohn SJ; Barrett K; Van Abbema A; Chang C; Kohli PB; Kanda H; Smith J; Lai Y; Zhou A; Zhang B; Yang W; Williams K; Macleod C; Hurley CA; Kulagowski JJ; Lewin-Koh N; Dengler HS; Johnson AR; Ghilardi N; Zak M; Liang J; Blair WS; Magnuson S; Wu LC J Immunol; 2013 Sep; 191(5):2205-16. PubMed ID: 23894201 [TBL] [Abstract][Full Text] [Related]
27. Synthetic Heterodimers of Type III Interferon Receptors Require TYK2 for STAT Activation. Mesev EV; Guare EG; Ploss A; Toettcher JE J Interferon Cytokine Res; 2023 Sep; 43(9):414-426. PubMed ID: 37725008 [TBL] [Abstract][Full Text] [Related]
29. Potent and Selective Knockdown of Tyrosine Kinase 2 by Antisense Oligonucleotides. Tran NV; Nguyen LTA; Lim KW; Phan AT Immunohorizons; 2021 Feb; 5(2):70-80. PubMed ID: 33542028 [TBL] [Abstract][Full Text] [Related]
30. English version of Japanese guidance for the use of oral Janus kinase inhibitors (JAK1 and TYK2 inhibitors) in the treatments of psoriasis. Saeki H; Mabuchi T; Asahina A; Abe M; Igarashi A; Imafuku S; Okubo Y; Komine M; Takahashi K; Torii H; Morita A; Yotsuyanagi H; Watanabe A; Ohtsuki M; J Dermatol; 2023 May; 50(5):e138-e150. PubMed ID: 37132187 [TBL] [Abstract][Full Text] [Related]
31. A novel highly selective allosteric inhibitor of tyrosine kinase 2 (TYK2) can block inflammation- and autoimmune-related pathways. Chen CX; Zhang W; Qu S; Xia F; Zhu Y; Chen B Cell Commun Signal; 2023 Oct; 21(1):287. PubMed ID: 37845748 [TBL] [Abstract][Full Text] [Related]
32. Constitutive STAT1 tyrosine phosphorylation in U937 monocytes overexpressing the TYK2 protein tyrosine kinase does not induce gene transcription. Eilers A; Kanda K; Klose B; Krolewski J; Decker T Cell Growth Differ; 1996 Jun; 7(6):833-40. PubMed ID: 8780896 [TBL] [Abstract][Full Text] [Related]
33. Tyk2 tyrosine kinase expression is required for the maintenance of mitochondrial respiration in primary pro-B lymphocytes. Potla R; Koeck T; Wegrzyn J; Cherukuri S; Shimoda K; Baker DP; Wolfman J; Planchon SM; Esposito C; Hoit B; Dulak J; Wolfman A; Stuehr D; Larner AC Mol Cell Biol; 2006 Nov; 26(22):8562-71. PubMed ID: 16982690 [TBL] [Abstract][Full Text] [Related]